Skip to main content
CivicGate

S 10277 NY

Authorizes high schools to include opioid overdose prevention and non-intravenous opioid antagonist administration as part of required health education courses

NY · session 2025-2026 · Senate · bill

A state bill is a proposed law in a state legislature — separate from the U.S. Congress. Learn more →

Introduced May 11, 2026

Latest action (May 11, 2026) REFERRED TO EDUCATION

Summary

This bill authorizes high schools to include opioid overdose prevention and non-intravenous opioid antagonist administration training as an optional part of required health education courses. Students who complete the training must demonstrate proficiency in using opioid antagonists and may be authorized to carry non-intravenous opioid antagonist medication such as naloxone on school property with written permission from their parents and a licensed healthcare provider. Schools may provide naloxone medication directly to students or maintain a supply on site for emergency use by trained school nurses, health professionals, employees, or students. Students authorized under this law may administer opioid antagonists to another person they believe is experiencing an opioid overdose, and must contact emergency medical services as soon as practicable. Schools and students acting in good faith under this law receive immunity from liability for administration of emergency care, provided their actions are not grossly negligent or willful misconduct.

AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.

Official abstract

Authorizes high schools to include opioid overdose prevention and non-intravenous opioid antagonist administration as optional part of required health education courses; authorizes certain students to administer non-intravenous opioid antagonists.

Sponsor (1)

Action history (1)

  1. May 11, 2026 REFERRED TO EDUCATION · upper

Text versions (2)

The published texts of this bill as it moves through the legislature. Each links to the official document on the state legislature site. Data from OpenStates.

  • S10277 · HTML
  • S10277 · PDF

Full text

Full text imported from assembly.state.ny.us

Skip to main content

New York State Assembly Speaker Carl E. Heastie

--> --> -->

Assembly Members

Legislative Info

Public Hearings

Speaker's Press

Assembly Reports

Committees & More

Bill Search Home Laws Legislative Calendar Public Hearing Schedule Assembly Calendars Assembly Committee Agenda Javascript must be enabled to properly view this page.

Bill No.: Summary Actions Committee&nbspVotes Floor&nbspVotes Memo Text LFIN Chamber&nbspVideo/Transcript S10277 Summary: BILL NO S10277 &nbsp SAME AS SAME AS A10060-A

&nbsp SPONSOR WEBB &nbsp COSPNSR &nbsp MLTSPNSR &nbsp Amd §804, add §922-a, Ed L &nbsp Authorizes high schools to include opioid overdose prevention and non-intravenous opioid antagonist administration as optional part of required health education courses; authorizes certain students to administer non-intravenous opioid antagonists.

Go to top S10277 Text:

STATE OF NEW YORK ________________________________________________________________________

10277

IN SENATE

May 11, 2026 ___________

Introduced by Sen. WEBB -- read twice and ordered printed, and when printed to be committed to the Committee on Education

AN ACT to amend the education law, in relation to health education in schools relating to opioid overdose prevention and non-intravenous opioid antagonist administration

The People of the State of New York, represented in Senate and Assem- bly, do enact as follows:

1 Section 1. Subdivisions 3 and 4 of section 804 of the education law, 2 as amended by chapter 390 of the laws of 2016, are amended to read as 3 follows: 4 3. Instruction regarding alcohol, tobacco, and other drugs shall be 5 included in the health education provided for all elementary school 6 pupils and shall be taught by the regular classroom teachers or by 7 teachers certified to teach health education , and by medical directors 8 and their designees . Such instruction shall be designed according to 9 the needs and abilities of the pupils at successive grade levels with 10 the purpose of developing desirable health behavior, attitudes, and 11 knowledge as well as self-reliance and problem solving capacity. 12 4. Instruction regarding alcohol, tobacco, and other drugs, in addi- 13 tion to continued health guidance in the junior high school grades and 14 the senior high schools, shall be an integral part of a required health 15 education course at each of these levels in the secondary schools 16 curriculum. Opioid overdose prevention and non-intravenous opioid 17 antagonist administration may additionally be an integral part of a 18 required health education course at the senior high school level. 19 Students shall be required to demonstrate knowledge in the subject area 20 through the use of a test, graded project or report, or any other means 21 prescribed by the school authorities regarding alcohol, drugs, and 22 tobacco. Any such course shall be taught by teachers holding a certif- 23 icate to teach health , and by medical directors and their designees. 24 High school students shall be required to demonstrate proficiency of the 25 use of opioid overdose antagonists as a life-saving treatment. School 26 districts may authorize opioid overdose prevention and non-intravenous 27 opioid antagonist administration training and may authorize students who

EXPLANATION--Matter in italics (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD14169-04-6

S. 10277 2

1 have successfully completed such training to possess non-intravenous 2 opioid antagonist medication for use as preventative first aid care . 3 Related courses in the secondary school curriculum shall be taught in a 4 manner supportive of health education regarding alcohol, tobacco, and 5 other drugs , and may be supportive of health education regarding opioid 6 overdose prevention and non-intravenous opioid antagonist 7 administration . In addition, instruction regarding the dangers of driv- 8 ing while under the influence of alcohol or drugs shall be an integral 9 part of a required health education course in the senior high schools. 10 Such instruction shall be provided in all senior high schools whether or 11 not these schools also provide driver education courses. Parents or 12 legal guardians shall be notified that their child will participate in 13 opioid overdose prevention training and non-intravenous opioid antag- 14 onist administration training and may submit a written request to the 15 school opting the student out of such training. 16 § 2. The education law is amended by adding a new section 922-a to 17 read as follows: 18 § 922-a. Non-intravenous opioid antagonists; carry, administration and 19 provision. 1. Definitions. For purposes of this section, the term "non- 20 intravenous opioid antagonist" shall mean naloxone or any other medica- 21 tion approved by the federal food and drug administration that is formu- 22 lated for administration by a route other than intravenous injection and 23 that is indicated for the emergency treatment of known or suspected 24 opioid overdose. 25 2. Carry and administration by students. (a) Any student may be 26 permitted to carry and administer a non-intravenous opioid antagonist 27 during the school day, on school property, on a school bus, and at any 28 school function defined in section eleven of this chapter provided that: 29 (i) the student has written permission from the student's parent or 30 person in parental relationship to the student to carry and administer a 31 non-intravenous opioid antagonist; and 32 (ii) the student has written permission from a licensed physician, 33 nurse practitioner or physician assistant, or other licensed health care 34 provider authorized to prescribe such medication to carry and administer 35 a non-intravenous opioid antagonist. Such written permission shall 36 include a statement that the student has been instructed in the proper 37 use of the non-intravenous opioid antagonist and is capable of carrying 38 and administering such medication. 39 (b) The written permissions required by paragraph (a) of this subdivi- 40 sion shall be provided to the school nurse or, in the absence of a 41 school nurse, to the school administrator designated by the board of 42 education, board of trustees, or other governing body. 43 3. Provision of non-intravenous opioid antagonists by schools. (a) A 44 school district, board of cooperative educational services, charter 45 school or non-public school may provide non-intravenous opioid antag- 46 onist medication directly to students for such students to retain on 47 their person for emergency use, consistent with the written permissions 48 required under subdivision two of this section and any guidance issued 49 by the department or the department of health. 50 (b) A school district, board of cooperative educational services, 51 charter school, or non-public school may acquire, store and maintain a 52 supply of non-intravenous opioid antagonists on site for emergency use 53 as preventive first aid care to be administered by a school nurse, other 54 duly licensed health professional, or any school employee or student 55 authorized and trained pursuant to applicable provisions of this chapter 56 and the public health law.

S. 10277 3

1 4. Use in emergencies. (a) A student who is authorized pursuant to 2 this section may administer a non-intravenous opioid antagonist to 3 another person whom the student in good faith believes is experiencing 4 an opioid overdose. 5 (b) Any person authorized to administer a non-intravenous opioid 6 antagonist pursuant to this section shall, as soon as practicable, 7 contact emergency medical services and otherwise act in accordance with 8 any applicable policies of the school district or other governing body. 9 5. Liability. A school district, board of cooperative educational 10 services, charter school, or non-public school, and any employee or 11 student acting in accordance with this section and any applicable guid- 12 ance or regulation, shall be deemed to be acting within the scope of 13 their duties and shall be afforded the same immunity from liability as 14 set forth in applicable provisions of this chapter and the public health 15 law for the administration of emergency care, provided that such acts 16 are not grossly negligent or willful or wanton misconduct. 17 § 3. This act shall take effect on the first of July next succeeding 18 the date on which it shall have become a law.

Go to top

Sitemap

Request Information

Directions and Maps

Comments

Comments

Loading comments…

Data from OpenStates. View on OpenStates →